Drug Products: Biologics, Biosimilars and Interchangeables
Prescription, Nonprescription and Orphan Drugs
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Dosage Regimen: Individualization
Drug Control Governance: Regulatory Bodies and Their Impact
Drug Regulation
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 16, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Bruce A Chabner1, Thomas G Roberts
1Clinical director for the Massachusetts General Hospital Cancer Center and a professor of medicine at Harvard Medical School.
No abstract available in PubMed .